Nanoparticles target anti-inflammatory drugs where needed

Feb 23, 2014
The bottom right of the image shows green-labeled neutrophils with red-labeled nanoparticles inside, which appear yellow. Credit: Zhenjia Wang

Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts. Their findings were published online Feb. 23 in Nature Nanotechnology.

The system uses made of tiny bits of protein designed to bind to unique receptors found only on neutrophils, a type of immune cell engaged in detrimental acute and chronic inflammatory responses.

In a normal immune response, neutrophils circulating in the blood respond to signals given off by injured or damaged blood vessels and begin to accumulate at the injury, where they engulf bacteria or debris from injured tissue that might cause infection. In chronic inflammation, neutrophils can pile up at the site of injury, sticking to the blood vessel walls and to each other and contributing to tissue damage.

Adhesion of neutrophils to is a major factor in , where it can impair the exchange of gases between the lungs and blood, leading to severe breathing problems. If untreated, the disease has a 50 percent mortality rate in intensive care units.

Corticosteroids and non-steroidal anti-inflammatory drugs used to treat are "blunt instruments that affect the whole body and carry some significant side effects," says Asrar B. Malik, the Schweppe Family Distinguished Professor and head of pharmacology in the UIC College of Medicine, who is lead author of the paper.

Neutrophils that are stuck to or clumped together have unique receptors on their surface that circulating neutrophils lack. Malik and his colleagues designed a nanoparticle to take advantage by embedding it with an anti-inflammatory drug. The nanoparticles bind to the receptors, and the neutrophils internalize the nanoparticle. Once inside, the anti-inflammatory drug works to "unzip" the neutrophil and allow it to re-enter the bloodstream.

"The nanoparticle is very much like a Trojan horse," Malik said. "It binds to a receptor found only on these activated, sticky neutrophils, and the cell automatically engulfs whatever binds there. Because circulating neutrophils lack these receptors, the system is incredibly precise and targets only those immune cells that are actively contributing to inflammatory disease."

Malik, along with research assistant professor Zhenjia Wang and assistant professor Jaehyung Cho, used intra-vital microscopy to follow nanoparticles in real-time in mice with induced vascular inflammation. The nanoparticles were labeled with a fluorescent dye, and could be seen binding to and entering neutrophils clustered together on the inner walls of capillaries, but not binding to freely circulating neutrophils. If the researchers attached a drug called piceatannol, which interferes with cell-cell adhesion, to the nanoparticles, they observed that clusters of that took up the particles detached from each other and from the blood vessel wall. The cells were in effect neutralized and could no longer contribute to inflammation at the site of an injury.

The findings, Malik said, "show that nanoparticles can be used to deliver drugs in a highly targeted, specific fashion to activated and could be designed to treat a broad range of inflammatory diseases."

Explore further: Jamming in tumors: How an immune molecule makes cancer cells starve

More information: Paper: dx.doi.org/10.1038/nnano.2014.17

add to favorites email to friend print save as pdf

Related Stories

Rogue blood cells may contribute to post-surgery organ damage

Jun 26, 2011

A study from scientists at Queen Mary, University of London, sheds new light on why people who experience serious trauma or go through major surgery, can suffer organ damage in parts of the body which are seemingly unconnected ...

Discarded immune cells induce the relocation of stem cells

May 23, 2013

Spanish researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today ...

Recommended for you

Nanotube cathode beats large, pricey laser

4 hours ago

Scientists are a step closer to building an intense electron beam source without a laser. Using the High-Brightness Electron Source Lab at DOE's Fermi National Accelerator Laboratory, a team led by scientist ...

User comments : 0